Psychiatry

Back to articles

Isotretinoin use is associated with psychiatric adverse events

KEY POINT

A review of data submitted to FDA’s Adverse Event Reporting System (FAERS) over 20 years showed that use of isotretinoin was associated with a variety of psychiatric adverse events, such as depressive disorders, emotional lability, and anxiety disorders. Further research is needed, however, to establish causality.